Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 15
Submit an article Journal homepage
250
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience

Huiqiang Huang H Huang, Q Cai and T Lin are co-first authors and contributed equally to this study.; Sun Yat-sen University, Cancer Center, Department of Medical Oncology, 651 E. Dongfeng Road, Guangzhou, 510060, PR China +86 20 8734 3349; +86 20 8734 2023; [email protected]
,
Qingqing Cai H Huang, Q Cai and T Lin are co-first authors and contributed equally to this study.; Sun Yat-sen University, Cancer Center, Department of Medical Oncology, 651 E. Dongfeng Road, Guangzhou, 510060, PR China +86 20 8734 3349; +86 20 8734 2023; [email protected]
,
Tianxin Lin H Huang, Q Cai and T Lin are co-first authors and contributed equally to this study.; Sun Yat-sen University, Second Affiliated Hospital, Department of Urology, Guangzhou, 510120, China
,
Xubin Lin Sun Yat-sen University, Cancer Center, Department of Medical Oncology, 651 E. Dongfeng Road, Guangzhou, 510060, PR China +86 20 8734 3349; +86 20 8734 2023; [email protected]
,
Yushan Liu Sun Yat-sen University, Cancer Center, Department of Medical Oncology, 651 E. Dongfeng Road, Guangzhou, 510060, PR China +86 20 8734 3349; +86 20 8734 2023; [email protected]
,
Yan Gao Sun Yat-sen University, Cancer Center, Department of Medical Oncology, 651 E. Dongfeng Road, Guangzhou, 510060, PR China +86 20 8734 3349; +86 20 8734 2023; [email protected]
&
Ruiqing Peng Sun Yat-sen University, Cancer Center, Department of Medical Oncology, 651 E. Dongfeng Road, Guangzhou, 510060, PR China +86 20 8734 3349; +86 20 8734 2023; [email protected]
 show all
Pages 2399-2406 | Published online: 17 Sep 2009

Bibliography

  • Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995;333:1540-5
  • Pettengell R, Radford JA, Morgenstern GR, et al. Survival benefit from high-dose therapy with autologous blood progenitor cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 1996;14:586-92
  • Cortelazzo S, Rossi A, Bellavita P, et al. Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI). Ann Oncol 1999;10:427-32
  • Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287-95
  • Wang F, Xu RH, Han B, et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007;109:1360-4
  • Chen MH, Hsiao LT, Chiou TJ, et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol 2008;87:475-80
  • Ozguroglu M, Bilici A, Turna H, et al. R eactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma. Med Oncol 2004;21:67-72
  • Li YH, He YF, Wang FH, et al. Clinical analysis of liver damage of 116 malignant lymphoma patients with chronic HBV infection after cytotoxic chemotherapy. Ai Zheng 2005;24:1507-9
  • Lau GKK, Liang R, Chiu EKW, et al. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 1997;19:795-9
  • Seth P, Alrajhi AA, Kagevi I, et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 2002;30:89-94
  • Dienstag JL, Perrillo RP, Schiff ER, et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657-61
  • Lai CL, Chien RN, Leung NW, et al. A one-year trial of lamivudine for chronic hepatitis B: Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998;339:61-8
  • Andreone P, Caraceni P, Grazi GL, et al. Lamivudine treatment for acute hepatitis B after liver transplantation. J Hepatol 1998;29:985-9
  • Lau GK, Yiu HH, Fong DY, et al. Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology 2003;125:1742-9
  • Yeo W, Chan PK, Ho WM, et al. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. J Clin Oncol 2004;22:927-34
  • Kohrt HE, Ouyang DL, Keeffe EB. Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther 2006;24:1003-16
  • Li YH, He YF, Jiang WQ, et al. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma. Cancer 2006;106:1320-5
  • Hsu C, Hsiung CA, Su IJ, et al. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology 2008;47:844-53
  • NCCN clinical practice guidelines in oncology: non-Hodgkin's lymphoma. Available from: http://www.nccn.org [Last accessed 25 November 2008]
  • Lau GKK, He ML, Fong DYT, et al. Preemptive use of lamivudine reduced hepatitis B exacerbation after allogeneic hematopoietic cell transplantation. Hepatology 2002;36:702-9
  • Lok AS, McMahon BJ. Chronic hepatitis B update of recommendations. Hepatology 2004;39:857-61
  • Vento S, Cainelli F, Longhi MS. Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue. Lancet Oncol 2002;3:333-40
  • Shibolet O, Ilan Y, Gillis S, et al. Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood 2002;100:391-6
  • Loomba R, Liang TJ. Novel approaches to new therapies for hepatitis B virus infection. Antivir Ther 2006;11:1-15
  • De Franchis R, Hadengue A, Lau G, et al. EASL Jury. EASL International Consensus Conference on Hepatitis B. 13 – 14 September 2002, Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003;39(Suppl 1):S3-25
  • Loomba R, Rowley A, Wesley R, et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 2008;148:519-28
  • Zhong S, Yeo W, Schroder C, et al. High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy. J Viral Hepat 2004;11:55-9
  • Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507-39
  • Ling R, Mutimer D, Ahmed N, et al. Selection of mutation in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996;24:711-13
  • Rivkin A. A review of entecavir in the treatment of chronic hepatitis B infection. Curr Med Res Opin 2005;21:1845-56
  • Endo T, Sakai T, Fujimoto K, et al. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant 2001;27:433-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.